Cyberhaven
Series D in 2025
Cyberhaven, Inc., established in 2014 and headquartered in Boston, Massachusetts, specializes in enterprise cybersecurity. The company's core offering is a Data Detection and Response platform designed to safeguard intellectual property from theft and insider threats. This platform assesses internal actions across an organization, identifying risky behaviors before they result in a breach. It provides full-context data tracing to minimize false positives and negatives, and accelerates incident response investigations, enabling clients to protect their data efficiently. Cyberhaven's technology covers the protection of sensitive documents across various platforms, including Office 365, on-premise SharePoint, and Google Apps. The company operates globally with additional offices in Palo Alto, California; Lausanne, Switzerland; and Kiev, Ukraine.
Highnote is an embedded finance company that offers a virtual payment platform designed to streamline complex payment processing flows. The platform allows product and engineering teams at digital enterprises to effortlessly integrate virtual and physical payment card capabilities—including prepaid, debit, credit, and charge cards—into their existing systems. By utilizing developer-friendly open APIs, Highnote provides a fully integrated issuer processor, granting businesses the control, flexibility, and speed needed to enhance their digital payment capabilities. This enables merchants and businesses to accelerate growth through effective payment transformation, delivering significant value to users and fostering unique brand differentiation.
Solera Health
Series E in 2025
Solera Health, Inc. is a preventive care benefits manager based in Phoenix, Arizona, that operates a technology platform designed to connect patients, payers, and physicians with community organizations and digital therapeutics companies. Founded in 2015, Solera's platform consolidates diverse healthcare programs into a single marketplace, facilitating increased consumer participation in health management. The company focuses on value-based health solutions, matching users with tailored programs that address a variety of health concerns, including hypertension, obesity, tobacco usage, diabetes prevention, mental health, and more. By linking members to appropriate health technologies and non-clinical healthcare providers, Solera aims to enhance the management and improvement of overall health outcomes for its users.
ZipHQ offers an intelligent purchase request platform that streamlines the process for employees to initiate purchase or vendor requests. The platform simplifies the creation of purchase requests, automatically routing them for approval across various departments, including procurement, finance, IT, and legal. By integrating with major ERP and P2P solutions, it facilitates the generation of purchase requisitions or draft purchase orders. Additionally, ZipHQ recommends preferred vendors and checks against price benchmarks to enhance cost efficiency and compliance. This comprehensive approach reduces the time spent coordinating approvals, ensuring a smooth and efficient purchasing process for organizations.
Level AI is a company based in Mountain View, California, that is transforming customer contact centers through its advanced conversational intelligence platform. This platform provides real-time insights that empower agents to assist customers efficiently and effectively during interactions. By automating tedious workflows, Level AI enhances the overall customer experience, allowing front-line workers to operate with the speed and intelligence of a supercomputer while maintaining a natural, human approach. The company is supported by prominent investors, including Battery Ventures, ENIAC, and Village Global, reflecting its potential to redefine how businesses manage customer interactions across various marketing channels.
BillionToOne
Series D in 2024
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.
Nomad Health
Series E in 2024
Nomad Health, Inc. operates an online marketplace that connects clinicians with freelance and permanent healthcare jobs across the United States. Founded in 2015 and headquartered in New York, the company provides a platform where doctors and nurses can search for job opportunities based on various criteria, including location, pay rate, and medical specialty. By digitizing the healthcare hiring process, Nomad Health simplifies and modernizes staffing in the healthcare sector, allowing healthcare facilities to efficiently find qualified clinicians. The platform also manages digital resumes and credentials, facilitating communication and organization between clinicians and health systems, while assisting with insurance, applications, travel arrangements, and payment processes.
Cyberhaven
Series C in 2024
Cyberhaven, Inc., established in 2014 and headquartered in Boston, Massachusetts, specializes in enterprise cybersecurity. The company's core offering is a Data Detection and Response platform designed to safeguard intellectual property from theft and insider threats. This platform assesses internal actions across an organization, identifying risky behaviors before they result in a breach. It provides full-context data tracing to minimize false positives and negatives, and accelerates incident response investigations, enabling clients to protect their data efficiently. Cyberhaven's technology covers the protection of sensitive documents across various platforms, including Office 365, on-premise SharePoint, and Google Apps. The company operates globally with additional offices in Palo Alto, California; Lausanne, Switzerland; and Kiev, Ukraine.
Altruist is a company focused on enhancing the accessibility and affordability of independent financial advice. It offers a digital investment platform that streamlines operations for financial advisors, automating research and helping identify client needs. By improving efficiency, Altruist empowers advisors to reduce their fees, allowing clients to pay less while increasing their financial confidence. The company supports thousands of financial professionals, ultimately benefiting tens of millions of individuals seeking a better experience with their finances.
Turquoise Health
Series B in 2024
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, Turquoise Health has developed a platform that enables users to browse and compare prices for elective services offered by hospitals. The platform facilitates price comparisons between various insurance services and allows individuals to search by procedure and provider. This innovative marketplace connects patients, providers, and payers, empowering individuals to save money on elective treatments while helping healthcare organizations attract both cash-paying and insured patients.
Cato Networks
Venture Round in 2023
Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform that integrates networking and security solutions for enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in locations such as California, the United Kingdom, Singapore, Hong Kong, and Australia, the company offers a secure global SD-WAN. Cato's platform connects various enterprise locations, personnel, and data while optimizing application access across all users and locations. Key features include WAN optimization, firewall protection, secure web gateways, and threat protection. Cato Networks enables organizations to reduce costs associated with MPLS, improve performance for global locations and cloud applications, and eliminate the need for branch appliances, all while providing secure internet access and integrating mobile users and cloud data centers into the network seamlessly.
Aircall, established in 2014 and headquartered in Paris, France, specializes in cloud-based call center software for startups and small to medium-sized businesses. Its core product, Aircall, is a SaaS application that enables companies to set up and manage phone support online, integrating seamlessly with popular productivity and helpdesk tools. The platform facilitates remote communication, monitors real-time metrics, and enhances both customer support and sales engagement. Aircall has a strategic partnership with Telarus Inc.
BillionToOne
Series C in 2022
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.
DispatchHealth
Venture Round in 2022
DispatchHealth Management, LLC is a provider of on-demand mobile and virtual healthcare services, founded in 2013 and headquartered in Denver, Colorado. The company offers a wide range of services, including evaluation and treatment for acute injuries and illnesses, laceration repair, splinting of injured extremities, and management of conditions like nosebleeds and catheter placements. It also facilitates medication administration, laboratory testing, outpatient imaging arrangements, and coordination with primary care physicians and home health agencies. By delivering care directly to patients in their homes or workplaces, DispatchHealth aims to enhance the capabilities of existing care teams while providing high-quality, cost-effective healthcare solutions.
US Med-Equip
Debt Financing in 2022
US Med-Equip, Inc. is a Houston-based company that specializes in the rental, sale, maintenance, and management of movable medical equipment for hospitals across the United States. Founded in 1995, the company offers a wide range of equipment, including anesthesia machines, beds, defibrillators, EKG machines, and respiratory devices, as well as furnishings like bassinets and recliners. US Med-Equip is recognized for its commitment to customer service, providing 24/7 support and personalized attention. The company is ISO 9001:2015 certified and employs advanced technology for equipment tracking and management, including an online platform called mySMARTS Portal and the STAR Trax Asset Management solution. In addition to rental and sales, US Med-Equip offers services such as biomedical repair, equipment buyouts, and preventative maintenance alerts, ensuring that healthcare providers can effectively manage their medical equipment and enhance patient care.
ClassDojo
Series D in 2022
ClassDojo, Inc. is an online school communication platform founded in 2011 and based in San Francisco, California. The platform connects teachers, students, and families, fostering close-knit communities that enhance the educational experience. It allows educators to share classroom activities, including photos and videos, and facilitates communication through features like Class Story and private messaging with parents. ClassDojo aims to engage students and their families by providing a space where learning can be shared and celebrated, ultimately enriching the educational environment and promoting collaboration both in and out of the classroom. The company, previously known as Class Twist, Inc., rebranded to ClassDojo, Inc. in December 2017.
Nomad Health
Venture Round in 2022
Nomad Health, Inc. operates an online marketplace that connects clinicians with freelance and permanent healthcare jobs across the United States. Founded in 2015 and headquartered in New York, the company provides a platform where doctors and nurses can search for job opportunities based on various criteria, including location, pay rate, and medical specialty. By digitizing the healthcare hiring process, Nomad Health simplifies and modernizes staffing in the healthcare sector, allowing healthcare facilities to efficiently find qualified clinicians. The platform also manages digital resumes and credentials, facilitating communication and organization between clinicians and health systems, while assisting with insurance, applications, travel arrangements, and payment processes.
FalconX, Ltd. is a cryptocurrency brokerage and digital asset trading platform founded in 2018 and based in San Mateo, California. The company specializes in blockchain technology and fintech, offering clients access to cryptocurrency markets for trading, credit, and clearing. FalconX utilizes data science and machine learning to ensure reliable execution of mid-to-large size trades, smart routing prices across multiple liquidity sources. This approach helps eliminate slippage and hidden fees, making it an attractive option for hedge funds, proprietary trading firms, and other institutional clients seeking efficient and cost-effective trading solutions.
Reify Health
Series D in 2022
Reify Health, Inc., founded in 2010 and based in Baltimore, Maryland, specializes in cloud-based software designed to enhance health behavior change measurement. Catering primarily to the life sciences industry, the company offers solutions that accelerate the development of new therapies by streamlining clinical research processes. Its flagship product, StudyTeam, supports clinical trial teams by improving enrollment timelines and research efficiency. This software provides research sponsors, contract research organizations (CROs), and clinical research sites with valuable insights into enrollment dynamics, allowing them to prioritize efforts that drive successful clinical outcomes. By reducing administrative burdens, Reify Health enables stakeholders to concentrate on activities that deliver the most significant impact on research productivity and budget management.
Remote is a global HR solutions provider that facilitates international hiring and payroll management for distributed teams. They offer a platform designed to help companies recruit top talent worldwide, ensuring compliance with local laws while streamlining project allocation and payments. This enables businesses to expand their workforce globally, enhancing productivity and employment opportunities.
BillionToOne
Series C in 2022
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.
Dremio Corporation, founded in 2015 and based in Santa Clara, California, develops a data lake engine that enhances the efficiency of data analytics. The platform allows users to execute SQL queries directly against data stored in lakes, eliminating the need for traditional data warehouses. By providing tools that streamline and curate data, Dremio accelerates analytical processes for business intelligence, data science, and machine learning applications. Its self-service capabilities empower data engineers, analysts, and scientists to work more productively and independently. Dremio's innovative approach facilitates faster access to insights, enabling organizations to derive greater value from their data without the complexities of data movement or transformation.
Nomad Health
Series D in 2021
Nomad Health, Inc. operates an online marketplace that connects clinicians with freelance and permanent healthcare jobs across the United States. Founded in 2015 and headquartered in New York, the company provides a platform where doctors and nurses can search for job opportunities based on various criteria, including location, pay rate, and medical specialty. By digitizing the healthcare hiring process, Nomad Health simplifies and modernizes staffing in the healthcare sector, allowing healthcare facilities to efficiently find qualified clinicians. The platform also manages digital resumes and credentials, facilitating communication and organization between clinicians and health systems, while assisting with insurance, applications, travel arrangements, and payment processes.
Reify Health
Series C in 2021
Reify Health, Inc., founded in 2010 and based in Baltimore, Maryland, specializes in cloud-based software designed to enhance health behavior change measurement. Catering primarily to the life sciences industry, the company offers solutions that accelerate the development of new therapies by streamlining clinical research processes. Its flagship product, StudyTeam, supports clinical trial teams by improving enrollment timelines and research efficiency. This software provides research sponsors, contract research organizations (CROs), and clinical research sites with valuable insights into enrollment dynamics, allowing them to prioritize efforts that drive successful clinical outcomes. By reducing administrative burdens, Reify Health enables stakeholders to concentrate on activities that deliver the most significant impact on research productivity and budget management.
Visier, Inc. is a developer of a cloud-based workforce intelligence platform that provides organizations with comprehensive analytics and solutions for managing their workforce. Founded in 2010 and headquartered in Vancouver, Canada, with an additional office in San Jose, California, Visier's offerings enable human resources professionals to efficiently recruit, retain, and develop talent while providing insights into workforce dynamics. The platform, known as Visier People, includes pre-built analytics that address a wide range of HR and business questions, facilitating strategic decision-making. It caters to various industries, including healthcare, financial services, technology, energy, manufacturing, and retail. Visier's subscription model ensures ongoing support and continuous delivery of new business value, enhancing the overall effectiveness of workforce planning and people analytics for its clients.
Aircall, established in 2014 and headquartered in Paris, France, specializes in cloud-based call center software for startups and small to medium-sized businesses. Its core product, Aircall, is a SaaS application that enables companies to set up and manage phone support online, integrating seamlessly with popular productivity and helpdesk tools. The platform facilitates remote communication, monitors real-time metrics, and enhances both customer support and sales engagement. Aircall has a strategic partnership with Telarus Inc.
Iterable, Inc. operates a consumer growth marketing and user engagement platform tailored for mid-market and enterprise B2C companies. Founded in 2013 and based in San Francisco, the company provides tools that allow marketers to communicate with users across multiple channels, including email, mobile, social media, and web. Its platform features capabilities such as real-time segmentation, automation, customization, and A/B testing. Additionally, Iterable supports engineers in triggering campaigns, managing user event data, and exporting campaign metrics. The company also offers specialized solutions for e-commerce, political marketing, and media companies, helping clients execute campaigns ranging from shopping cart abandonment notifications to transactional messages. By leveraging artificial intelligence and behavior-driven data, Iterable enables organizations to engage customers effectively throughout their lifecycle, enhancing customer interactions and driving growth.
Homeward, Inc. is a real estate technology company based in Austin, Texas, that facilitates home buying and selling services. Established in 2018, the company allows buyers to make all-cash offers on new homes before selling their existing properties, thus streamlining the purchasing process. Through its platform, known as The Homeward Way, users can find homes and receive credit to enhance their purchasing power. Homeward also provides rental solutions for new homes while customers sell their current properties, alleviating the stress associated with market sales and financing contingencies. The company primarily operates in Texas, Georgia, and Colorado, with plans to expand its services to agents and home buyers across the United States. Homeward aims to support real estate agents and their clients by offering accurate home valuations and innovative financing options that address the challenges of traditional mortgages.
Actium Health
Series B in 2021
Actium Health specializes in enhancing consumer engagement within the healthcare sector by leveraging health-system data intelligence. The company has developed a healthcare customer relationship management platform that utilizes machine learning and predictive analytics to analyze clinical and payer data. This approach allows healthcare providers to identify actionable insights, which can lead to improved patient engagement and retention. By offering AI-driven recommendations tailored to individual needs and personalized activation tools, Actium Health aims to unlock additional value for healthcare organizations. This, in turn, supports the management of high-risk patients, fosters growth in service lines, and cultivates loyalty among patients, ultimately enhancing their lifetime value.
ThreatQuotient
Debt Financing in 2021
ThreatQuotient, Inc. is a cybersecurity company that specializes in developing a threat intelligence platform designed to help organizations effectively manage and respond to cyber threats. Founded in 2013 and headquartered in Reston, Virginia, the company offers its flagship product, ThreatQ, which integrates and correlates various external threat sources with internal security solutions to provide contextualized intelligence. This platform streamlines security operations by reducing noise, prioritizing threats, and facilitating collaboration among teams. It features capabilities such as Indicator Nurturing, which tailors indicators of compromise to specific infrastructures, as well as integrations with existing security tools and processes. ThreatQuotient's solutions support a range of use cases, including incident response and threat hunting, ultimately enhancing the efficiency and effectiveness of security operations. The company has received multiple awards for its product excellence and industry leadership, reflecting its commitment to advancing cybersecurity practices. Additionally, ThreatQuotient operates internationally, with a presence in Germany and Australia.
ThreatQuotient
Venture Round in 2021
ThreatQuotient, Inc. is a cybersecurity company that specializes in developing a threat intelligence platform designed to help organizations effectively manage and respond to cyber threats. Founded in 2013 and headquartered in Reston, Virginia, the company offers its flagship product, ThreatQ, which integrates and correlates various external threat sources with internal security solutions to provide contextualized intelligence. This platform streamlines security operations by reducing noise, prioritizing threats, and facilitating collaboration among teams. It features capabilities such as Indicator Nurturing, which tailors indicators of compromise to specific infrastructures, as well as integrations with existing security tools and processes. ThreatQuotient's solutions support a range of use cases, including incident response and threat hunting, ultimately enhancing the efficiency and effectiveness of security operations. The company has received multiple awards for its product excellence and industry leadership, reflecting its commitment to advancing cybersecurity practices. Additionally, ThreatQuotient operates internationally, with a presence in Germany and Australia.
Mineralys Therapeutics
Series A in 2021
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for hypertension. The company is advancing its lead product candidate, MLS-101, a highly selective and potent aldosterone synthase inhibitor licensed from Mitsubishi Tanabe Pharma Corporation. Mineralys aims to provide a targeted treatment for patients with uncontrolled hypertension, particularly those who do not achieve adequate blood pressure control despite using multiple antihypertensive medications. By addressing the underlying factors associated with elevated aldosterone levels, Mineralys seeks to improve treatment outcomes for individuals suffering from this condition.
Advise Insurance
Series A in 2021
Advise Insurance is a Medicare concierge agency dedicated to assisting seniors in their communities with health insurance selection and enrollment. The agency offers comprehensive services that promote healthy living for seniors, focusing on maintaining strong connections between patients and their healthcare providers. Advise Health Holdings, the parent company, also oversees Bloom Insurance, which is a Medicare enrollment platform that operates with licensed agents throughout the contiguous United States. Through partnerships with healthcare professionals, Advise Insurance provides informative seminars on Medicare and facilitates a transparent comparison of various Medicare plans, ensuring that elderly individuals receive the necessary guidance to choose the healthcare options that best suit their needs.
Redox, Inc. is a healthtech startup incubator and venture capital firm founded in 2014, based in Madison, Wisconsin. The company specializes in early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices. Redox accelerates the development and distribution of healthcare software solutions through its full-service integration platform, designed to facilitate secure and efficient data exchange between healthcare delivery organizations and technology vendors. By creating a comprehensive interoperable network, Redox enables these entities to connect and authorize data sharing, ultimately enhancing patient experiences. The firm focuses on removing technical barriers in healthcare systems, standardizing data, and maintaining integrations, allowing vendors and providers to prioritize the delivery of reliable healthcare services.
PerimeterX
Series D in 2021
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.
Freeman Spogli
Debt Financing in 2020
Freeman Spogli Management Co., L.P., established in 1983, is a private equity firm headquartered in Los Angeles, California, with an additional office in New York. The company specializes in acquiring middle-market companies, providing growth capital, and facilitating leveraged recapitalizations, management buyouts, and corporate carve-outs. Freeman Spogli primarily invests in the consumer sector, focusing on retail, restaurants, direct marketing, e-commerce, consumer products, and retail services, as well as the distribution sector, with an emphasis on wholesale and business-to-business distribution. The firm typically invests between $25 million and $150 million in equity, targeting companies with enterprise values between $100 million and $700 million and EBITDA between $10 million and $50 million. Freeman Spogli seeks board seats in its portfolio companies and may also participate in add-on acquisition opportunities.
Robinhood
Series F in 2020
Robinhood Financial LLC is an online brokerage firm that provides commission-free trading services to self-directed investors through its mobile application and website. Established in 2012 and headquartered in Menlo Park, California, the company, previously known as Chronos Financial, LLC, rebranded in 2013. As a subsidiary of Robinhood Markets, Inc., Robinhood offers a comprehensive platform for trading stocks, options, exchange-traded funds (ETFs), and cryptocurrencies. The firm aims to democratize access to financial markets, allowing users to trade and manage their investments easily. Its innovative platform includes features such as fractional shares, recurring investments, and IPO access. Robinhood generates revenue primarily by routing user orders to market makers, facilitating transactions across various asset classes.
Palvella Therapeutics
Series C in 2020
Palvella Therapeutics, based in Wayne, Pennsylvania, is a clinical-stage biopharmaceutical company established in 2015. It focuses on developing and commercializing targeted therapies for serious and rare genetic skin diseases, specifically genodermatoses. The company's lead product, QTORIN, is a specialized anhydrous gel designed to deliver active ingredients effectively into the skin, addressing the underlying causes of various dermatological conditions. Palvella's pipeline includes candidates aimed at treating microcystic lymphatic malformations and cutaneous venous malformations, utilizing its proprietary QTORIN platform to offer innovative solutions for underserved patient populations.
Aircall, established in 2014 and headquartered in Paris, France, specializes in cloud-based call center software for startups and small to medium-sized businesses. Its core product, Aircall, is a SaaS application that enables companies to set up and manage phone support online, integrating seamlessly with popular productivity and helpdesk tools. The platform facilitates remote communication, monitors real-time metrics, and enhances both customer support and sales engagement. Aircall has a strategic partnership with Telarus Inc.
Couchbase
Series G in 2020
Couchbase, Inc. is a provider of NoSQL databases tailored for enterprises, particularly for web and mobile applications. The company offers a comprehensive Couchbase platform that includes Couchbase Server, a high-performance distributed database, Couchbase Lite, an embedded database for mobile devices, and Couchbase Sync Gateway, which synchronizes data between mobile devices and the cloud. Additionally, Couchbase provides a cloud-native autonomous database management platform through its Kubernetes Operator and a fully-managed Database-as-a-Service (DBaaS) known as Couchbase Cloud. The platform is designed to handle massive data volumes in real time, making it suitable for industries such as social networking, online gaming, advertising, and e-commerce. Headquartered in Santa Clara, California, with an office in Manchester, United Kingdom, Couchbase was founded in 2008 and rebranded from Membase, Inc. in 2011. The company focuses on empowering developers to create innovative and personalized customer experiences through its agile and scalable database solutions.
Homeward
Venture Round in 2020
Homeward, Inc. is a real estate technology company based in Austin, Texas, that facilitates home buying and selling services. Established in 2018, the company allows buyers to make all-cash offers on new homes before selling their existing properties, thus streamlining the purchasing process. Through its platform, known as The Homeward Way, users can find homes and receive credit to enhance their purchasing power. Homeward also provides rental solutions for new homes while customers sell their current properties, alleviating the stress associated with market sales and financing contingencies. The company primarily operates in Texas, Georgia, and Colorado, with plans to expand its services to agents and home buyers across the United States. Homeward aims to support real estate agents and their clients by offering accurate home valuations and innovative financing options that address the challenges of traditional mortgages.
Epirium Bio
Series A in 2019
Epirium Bio, Inc. is a San Diego-based biopharmaceutical company focused on developing therapeutic compounds for cardiovascular diseases, metabolic syndrome, and various conditions related to mitochondrial dysfunction. Founded in 2008 and previously known as Cardero Therapeutics, Epirium Bio utilizes innovative insights into mitochondrial biology and tissue regeneration to create small molecule therapies. The company's research is aimed at enhancing muscle strength and supporting the treatment of neuromuscular and neurodegenerative disorders, including conditions such as muscular dystrophy. Through its novel approaches, Epirium Bio seeks to provide clinically significant solutions for patients suffering from these challenging diseases.
Punchh Inc. provides a mobile loyalty and engagement platform designed to enhance customer relationships for the restaurant industry. Founded in 2010 and headquartered in San Mateo, California, the company offers a suite of solutions that includes branded mobile applications for loyalty programs, referral incentives, online ordering, and payment processing. By integrating its platform with existing point-of-sale systems and various social networks, Punchh enables restaurants to gather insights into customer behavior and preferences. Its technology employs artificial intelligence and machine learning to create personalized customer experiences, allowing brands to engage effectively and increase customer lifetime value. With a client base that includes nearly 200 global enterprise brands, Punchh operates not only in the United States but also has a presence in Canada, India, the United Kingdom, and Singapore, facilitating a comprehensive approach to customer retention and remarketing across multiple channels.
Icosavax, Inc. is a biotechnology company based in Seattle, Washington, founded in 2017. The company specializes in developing vaccines using its innovative virus-like particle (VLP) technology platform, which allows for the multivalent display of complex viral antigens. This technology aims to provide broad and durable protection against various infectious diseases, with an initial focus on life-threatening respiratory illnesses. Icosavax's pipeline includes vaccine candidates targeting respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and SARS-CoV-2. The company is dedicated to advancing its VLP technology to discover, develop, and ultimately commercialize effective vaccines against these infectious diseases.
PerimeterX
Series C in 2019
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.
VillageMD
Series B in 2019
VillageMD is a healthcare management services company focused on supporting primary care physicians. Founded in 2013 and headquartered in Chicago, Illinois, the company provides a comprehensive platform that includes tools, technology, operations, and staffing support. It collaborates with physician groups, independent practice associations, and health systems to enhance quality of care, improve patient experiences, and reduce costs. VillageMD's services encompass management, clinical innovation, analytics, and value-based contract negotiation, enabling healthcare providers to achieve better clinical outcomes across various populations. The company operates in multiple markets, including Chicago, Georgia, Houston, Indianapolis, Kentucky, Michigan, New Hampshire, and Austin.
MyHealthTeam
Series B in 2019
MyHealthTeams, Inc., established in 2011 and headquartered in San Francisco, develops and operates online social networking platforms for individuals living with or caring for those with chronic health conditions. The company's platforms, including MyAutismTeam, MyBCTeam, and others, connect users with similar conditions, enabling them to share experiences, seek advice, and access medically-approved content. MyHealthTeams also conducts research to inform clinical trial design and offers patient education programs.
TurnKey Vacation Rentals
Series E in 2019
TurnKey Vacation Rentals is a full-service property management company specializing in luxury and premium vacation rental homes in sought-after U.S. travel destinations. The company is recognized for delivering a consistent and high-quality guest experience akin to that of a fine hotel, while simultaneously enhancing the management and marketing efforts for vacation rental homeowners. TurnKey utilizes proprietary smart home technology, including digital smart locks and noise decibel monitors, to streamline operations and improve guest satisfaction. By integrating local teams with advanced technology, TurnKey aims to provide exceptional experiences for both guests and homeowners, ensuring every stay meets high standards of quality and service.
Actium Health
Series A in 2019
Actium Health specializes in enhancing consumer engagement within the healthcare sector by leveraging health-system data intelligence. The company has developed a healthcare customer relationship management platform that utilizes machine learning and predictive analytics to analyze clinical and payer data. This approach allows healthcare providers to identify actionable insights, which can lead to improved patient engagement and retention. By offering AI-driven recommendations tailored to individual needs and personalized activation tools, Actium Health aims to unlock additional value for healthcare organizations. This, in turn, supports the management of high-risk patients, fosters growth in service lines, and cultivates loyalty among patients, ultimately enhancing their lifetime value.
Solera Health
Series C in 2019
Solera Health, Inc. is a preventive care benefits manager based in Phoenix, Arizona, that operates a technology platform designed to connect patients, payers, and physicians with community organizations and digital therapeutics companies. Founded in 2015, Solera's platform consolidates diverse healthcare programs into a single marketplace, facilitating increased consumer participation in health management. The company focuses on value-based health solutions, matching users with tailored programs that address a variety of health concerns, including hypertension, obesity, tobacco usage, diabetes prevention, mental health, and more. By linking members to appropriate health technologies and non-clinical healthcare providers, Solera aims to enhance the management and improvement of overall health outcomes for its users.
GoCardless
Series E in 2019
GoCardless Limited, established in 2011 and headquartered in London, specializes in online payment processing services for businesses. It facilitates bank-to-bank transfers through web-based gateways and APIs, enabling merchants to collect one-off and recurring payments. The company's key products include GoCardless for simple online payments, GoCardless Pro for building recurring payment ecosystems, and Success+ for predicting and managing payment failures. GoCardless offers international payment collection, with connections to over 2,300 banks across Europe, and securely provides bank account data to enhance products and manage risk. With strategic alliances like Zuora, Inc., GoCardless serves over 75,000 businesses worldwide, operating from offices in London, Paris, Munich, Melbourne, and New York.
PerimeterX
Series C in 2019
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.
Inspira Financial
Private Equity Round in 2019
Inspira Financial is a provider of technology-enabled solutions focused on health, wealth, retirement, and benefits, aimed at simplifying the financial journey for individuals and institutions. The company serves over 7 million clients with more than $62 billion in assets under custody, collaborating with thousands of employers, plan sponsors, recordkeepers, and third-party administrators. Inspira Financial offers a range of services, including automatic rollover solutions, health savings accounts, emergency savings funds, and custody services, all designed to help clients effectively plan, save, and invest for a secure future. Through its innovative approach, Inspira Financial is dedicated to improving outcomes for clients and their beneficiaries.
Arctic Wolf
Series C in 2018
Arctic Wolf Networks, Inc., established in 2012 and headquartered in Eden Prairie, Minnesota, specializes in providing comprehensive cybersecurity solutions to businesses. The company offers a suite of services including Managed Detection and Response, Managed Risk, and Managed Cloud Monitoring, delivered through its unique concierge security team model. This approach extends the capabilities of clients' internal teams, offering tailored threat detection, response, and ongoing risk management. Arctic Wolf's platform employs continuous vulnerability assessment, real-time monitoring, and machine learning to provide actionable insights and alerts, enabling businesses to proactively combat cyber threats without needing to invest in their own security operations center. The company serves a diverse range of industries, with a particular focus on financial services, healthcare, legal enterprises, and other mid-to-large sized organizations.
Qpex Biopharma
Series A in 2018
Qpex Biopharma is a San Diego-based biopharmaceutical company founded in 2018, focused on developing innovative therapies to address the growing challenge of antimicrobial resistance. The company specializes in creating a pipeline of antibiotic drugs aimed at treating infectious diseases in both inpatient and outpatient settings. With a strong emphasis on the discovery, development, and regulatory approval of anti-infective medicines, Qpex Biopharma leverages its expertise and experience in collaboration with public and private partnerships to meet critical medical needs. The company's mission is to provide effective solutions for healthcare professionals facing the complexities of resistant infections, thereby enhancing treatment options for patients.
Cirius Therapeutics
Series A in 2018
Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to developing and commercializing therapies for liver and metabolic diseases. Founded in 2015 and headquartered in San Diego, California, the company focuses on its lead product candidate, MSDC-0602K, an oral small molecule currently undergoing Phase 2b clinical trials for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis. This next-generation insulin sensitizer aims to address the underlying pathophysiology of NASH, a condition characterized by fat accumulation and inflammation in the liver that can lead to severe complications such as cirrhosis and liver cancer. Cirius Therapeutics is committed to providing innovative solutions to healthcare providers for managing liver and metabolic diseases.
Millendo Therapeutics
Venture Round in 2018
Millendo Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for endocrine diseases resulting from hormone dysregulation. The company focuses on creating distinct and transformative therapies that address significant unmet medical needs in this area. By leveraging scientific advancements, Millendo aims to develop novel compounds that can effectively treat complex conditions, ultimately enhancing clinical care and improving the quality of life for patients, families, and caregivers.
TurnKey Vacation Rentals
Series D in 2018
TurnKey Vacation Rentals is a full-service property management company specializing in luxury and premium vacation rental homes in sought-after U.S. travel destinations. The company is recognized for delivering a consistent and high-quality guest experience akin to that of a fine hotel, while simultaneously enhancing the management and marketing efforts for vacation rental homeowners. TurnKey utilizes proprietary smart home technology, including digital smart locks and noise decibel monitors, to streamline operations and improve guest satisfaction. By integrating local teams with advanced technology, TurnKey aims to provide exceptional experiences for both guests and homeowners, ensuring every stay meets high standards of quality and service.
Cofense
Venture Round in 2018
Cofense specializes in anti-phishing threat management solutions, protecting businesses from phishing, malware, and drive-by attacks. Its key offerings include Cofense Triage for real-time attack insights, Cofense Reporter for employee reporting of suspicious emails, and Cofense Vision for comprehensive attack understanding. Additionally, Cofense provides intelligence services, a learning management system for cybersecurity awareness, and professional services such as consulting. Serving a wide range of industries, Cofense's platform leverages a global network of trained employees to report suspected threats, enhancing detection and response capabilities that complement existing email gateway technologies.
Dynamic Signal
Series E in 2018
Dynamic Signal, established in 2010 and headquartered in San Bruno, California, specializes in employee communication and engagement. Its platform connects companies with their employees, facilitating the dissemination of timely, relevant content across various channels and devices. This enhances productivity, fosters employee engagement, and amplifies corporate messaging. Dynamic Signal serves hundreds of global enterprises, including 85 Fortune 500 companies, such as IBM, Salesforce, and Edelman.
Partner Therapeutics
Series A in 2018
Partner Therapeutics, Inc. is an oncology company based in Lexington, Massachusetts, dedicated to the development and commercialization of approved and late-stage cancer therapies. The company focuses on improving treatment outcomes and reducing overall healthcare costs for cancer patients through a comprehensive range of therapies, from primary treatments to supportive care. One of its key products is Leukine, which promotes the growth of white blood cells to aid in cancer treatment. Founded in 2017, Partner Therapeutics aims to connect investigators and healthcare professionals in the field of oncology, ensuring effective treatments are accessible to patients at all stages of their cancer journey.
MATRIXX Software
Series C in 2018
MATRIXX Software, Inc. specializes in developing cloud-native digital commerce solutions that enable businesses to transform their operations. The company's modern commerce platform is designed to support global marketplaces and consumption-based services, allowing users to create digital offerings such as voice, data, and new digital services. Its platform enables customers to engage in on-demand purchasing, manage both traditional and modern services, and implement flexible charging options, including prepay and post-pay systems. Serving communications companies, Internet of Things (IoT) providers, and digital service providers worldwide, MATRIXX Software offers a unified converged charging system that enhances operational agility and facilitates the efficient scaling of infrastructure. Founded in 2008, the company is headquartered in Saratoga, California, with additional offices in London, Dubai, and various locations across Asia and Australia.
Therapy Brands
Venture Round in 2018
Therapy Brands is a provider of software solutions specifically designed for mental and behavioral health practitioners. Headquartered in Birmingham, Alabama, the company offers fully integrated practice management and electronic health record systems tailored for various segments, including psychiatric care, substance use recovery, rehabilitation, and applied behavior analysis. By delivering a comprehensive suite of tools, Therapy Brands enables healthcare providers to enhance patient care and achieve better health outcomes. Their solutions streamline essential functions such as practice management, telehealth, revenue cycle management, e-Prescribing, and payment processing. This focus on operational efficiency allows therapists, psychologists, social workers, and counselors to reduce administrative burdens, thereby dedicating more time to patient interactions and improving overall service delivery.
Atox Bio Inc. is a biotechnology company based in Ness Ziona, Israel, with an additional office in North Carolina. Founded in 2003, the company specializes in developing immunomodulators aimed at treating critically ill patients suffering from severe infections and acute inflammatory conditions. Atox Bio focuses on novel therapies that target multiple pathways within both the adaptive and innate immune responses, which are crucial in managing infectious diseases, inflammatory disorders, and ischemia/reperfusion injuries. The company’s products are designed to address serious medical conditions with high morbidity and mortality, showing promising results in improving patient outcomes and reducing tissue damage during acute inflammatory events.
Outpost Medicine
Series A in 2017
Outpost Medicine, founded in 2016 and based in the United States, focuses on developing innovative therapeutics for urologic and gynecologic diseases and disorders. The company is dedicated to addressing gastrointestinal and urologic conditions, with its lead clinical-stage product candidate, OP-233, aimed at treating stress urinary incontinence (SUI), a condition characterized by involuntary urine loss during physical activities. Additionally, Outpost is working on treatments for overactive bladder (OAB) and irritable bowel syndrome (IBS), reflecting its commitment to advancing healthcare solutions in these areas.
ThreatQuotient
Series C in 2017
ThreatQuotient, Inc. is a cybersecurity company that specializes in developing a threat intelligence platform designed to help organizations effectively manage and respond to cyber threats. Founded in 2013 and headquartered in Reston, Virginia, the company offers its flagship product, ThreatQ, which integrates and correlates various external threat sources with internal security solutions to provide contextualized intelligence. This platform streamlines security operations by reducing noise, prioritizing threats, and facilitating collaboration among teams. It features capabilities such as Indicator Nurturing, which tailors indicators of compromise to specific infrastructures, as well as integrations with existing security tools and processes. ThreatQuotient's solutions support a range of use cases, including incident response and threat hunting, ultimately enhancing the efficiency and effectiveness of security operations. The company has received multiple awards for its product excellence and industry leadership, reflecting its commitment to advancing cybersecurity practices. Additionally, ThreatQuotient operates internationally, with a presence in Germany and Australia.
Fusion Pharmaceuticals
Series A in 2017
Fusion Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company headquartered in Hamilton, Canada, specializing in the development of radiopharmaceuticals as precision medicines for challenging cancers. The company employs its proprietary Targeted Alpha Therapies platform and Fast-Clear linker technology to connect alpha particle-emitting isotopes to antibodies, enabling the selective delivery of therapeutic agents to tumors. Fusion's lead product candidate, FPI-1434, is currently undergoing Phase 1 clinical trials as a monotherapy for solid tumors expressing insulin-like growth factor 1 receptor. Additionally, the company is exploring the use of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors in preclinical studies to enhance anti-tumor activity. Fusion is also advancing another product candidate, FPI-1966, into clinical development for head and neck and bladder cancers that express fibroblast growth factor receptor. Founded in 2014 as a spinout of the Centre for Probe Development and Commercialization, Fusion aims to transform how cancers are treated through innovative radiochemistry techniques.
Lever, Inc. is a talent acquisition platform that offers a comprehensive web application designed to streamline the hiring process for organizations. Based in San Francisco, the company provides a suite of tools that facilitate job postings, employee referrals, communication, decision-making, sourcing, interviews, and reporting. Its flagship product, LeverTRM, combines applicant tracking system (ATS) and customer relationship management (CRM) functionalities, allowing talent teams to effectively manage their hiring goals and foster connections with potential candidates. The platform's features, such as Lever Hire and Lever Nurture, help organizations build a robust talent pipeline and maintain meaningful relationships with candidates. Additionally, Lever Analytics provides customized reports and data visualization to support informed decision-making for hiring managers and executives. With a commitment to inclusivity, Lever aims to reduce hiring bias and has successfully supported the recruitment efforts of over 3,800 global companies.
Solera Health
Series B in 2017
Solera Health, Inc. is a preventive care benefits manager based in Phoenix, Arizona, that operates a technology platform designed to connect patients, payers, and physicians with community organizations and digital therapeutics companies. Founded in 2015, Solera's platform consolidates diverse healthcare programs into a single marketplace, facilitating increased consumer participation in health management. The company focuses on value-based health solutions, matching users with tailored programs that address a variety of health concerns, including hypertension, obesity, tobacco usage, diabetes prevention, mental health, and more. By linking members to appropriate health technologies and non-clinical healthcare providers, Solera aims to enhance the management and improvement of overall health outcomes for its users.
MyHealthTeam
Series A in 2017
MyHealthTeams, Inc., established in 2011 and headquartered in San Francisco, develops and operates online social networking platforms for individuals living with or caring for those with chronic health conditions. The company's platforms, including MyAutismTeam, MyBCTeam, and others, connect users with similar conditions, enabling them to share experiences, seek advice, and access medically-approved content. MyHealthTeams also conducts research to inform clinical trial design and offers patient education programs.
Mintigo Inc. is a company that develops an artificial intelligence-based customer engagement and predictive analytics platform aimed at enhancing B2B marketing and lead generation. Founded in 2009 and headquartered in San Mateo, California, Mintigo's platform assists businesses in identifying potential purchases by specific customers, thereby enabling more effective marketing strategies. Key features of the platform include predictive ideal customer profile (ICP) discovery, prioritization of fit and buying stages, predictive audience generation, and account-based marketing (ABM) support. The platform also facilitates new pipeline generation, customer marketing upsell and cross-sell opportunities, insight-driven engagement, and sales enablement. Mintigo's clientele includes notable companies such as Getty Images, Oracle, and Red Hat, who utilize its services to enhance their marketing efforts and optimize the sales cycle. As of October 2019, Mintigo operates as a subsidiary of Anaplan, Inc.
Smule, Inc. is a San Francisco-based company that specializes in developing music applications aimed at connecting users through collaborative music creation. Founded in 2008, Smule's platform allows individuals to sing and produce music together, fostering a global community of music enthusiasts. Its popular products include AutoRap, Magic Piano, Guitar!, I Am T-Pain, and Ocarina, which enable users to create, discover, and enjoy music in innovative ways. By combining social interaction with music-making, Smule has established itself as a leader in the music app industry, facilitating connections between users and major artists worldwide.
Snow Software
Venture Round in 2017
Snow Software is a technology intelligence company that specializes in asset management software aimed at helping organizations effectively manage their technology consumption. Its platform offers comprehensive visibility and insight into software, SaaS, hardware, and cloud resources. By automating the reconciliation of license entitlements with actual software installations and monitoring both cloud and on-premise usage, Snow Software enables clients to optimize their software licenses and reduce costs. Additionally, the platform features mobile license management, user authentication, and advanced analytics, which equip IT leaders with the necessary tools to enhance performance and operational agility in a hybrid work environment.
Cirius Therapeutics
Series A in 2017
Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to developing and commercializing therapies for liver and metabolic diseases. Founded in 2015 and headquartered in San Diego, California, the company focuses on its lead product candidate, MSDC-0602K, an oral small molecule currently undergoing Phase 2b clinical trials for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis. This next-generation insulin sensitizer aims to address the underlying pathophysiology of NASH, a condition characterized by fat accumulation and inflammation in the liver that can lead to severe complications such as cirrhosis and liver cancer. Cirius Therapeutics is committed to providing innovative solutions to healthcare providers for managing liver and metabolic diseases.
Visier, Inc. is a developer of a cloud-based workforce intelligence platform that provides organizations with comprehensive analytics and solutions for managing their workforce. Founded in 2010 and headquartered in Vancouver, Canada, with an additional office in San Jose, California, Visier's offerings enable human resources professionals to efficiently recruit, retain, and develop talent while providing insights into workforce dynamics. The platform, known as Visier People, includes pre-built analytics that address a wide range of HR and business questions, facilitating strategic decision-making. It caters to various industries, including healthcare, financial services, technology, energy, manufacturing, and retail. Visier's subscription model ensures ongoing support and continuous delivery of new business value, enhancing the overall effectiveness of workforce planning and people analytics for its clients.
TurnKey Vacation Rentals
Series C in 2017
TurnKey Vacation Rentals is a full-service property management company specializing in luxury and premium vacation rental homes in sought-after U.S. travel destinations. The company is recognized for delivering a consistent and high-quality guest experience akin to that of a fine hotel, while simultaneously enhancing the management and marketing efforts for vacation rental homeowners. TurnKey utilizes proprietary smart home technology, including digital smart locks and noise decibel monitors, to streamline operations and improve guest satisfaction. By integrating local teams with advanced technology, TurnKey aims to provide exceptional experiences for both guests and homeowners, ensuring every stay meets high standards of quality and service.
Scytl is a leading provider of electronic voting and electoral modernization solutions, specializing in secure and auditable electoral processes. Established in 2001 as a spin-off from a university research group, the company has developed a robust patent portfolio, holding over 40 international patents focused on election security. Its technology employs advanced cryptographic protocols, ensuring maximum security, transparency, and auditability for electoral events. Scytl has successfully managed over 100,000 electoral events in more than 35 countries, demonstrating its commitment to innovation and reliability in election administration. The company's solutions have been rigorously audited by independent organizations and academic experts, affirming compliance with high security standards. Headquartered in Barcelona, Spain, Scytl also operates strategic offices in Canada, the United States, Peru, and Greece, along with field offices in various countries. The company has experienced substantial growth, establishing a strong financial reputation within the industry.
Included Health
Venture Round in 2017
Included Health is a healthcare company that provides a blend of virtual care, navigation, and community-based healthcare services to enhance the member experience. It combines advanced technology and a compassionate approach to deliver personalized care guidance and advocacy, ensuring that individuals receive the right care at the right time. The company's offerings include access to both virtual and in-person services for a range of healthcare needs, including urgent and primary care, behavioral health, and specialty care. By focusing on a member-centric model, Included Health aims to raise the standard of healthcare for everyone, making it simpler and more effective for individuals to navigate their health journey.
Tripping.com
Series C in 2016
Tripping International, Inc. operates Tripping.com, a leading metasearch platform for vacation homes and short-term rentals globally. Launched in 2010 and based in San Francisco, the platform allows users to search, compare, and book accommodations from various partner rental sites, catering to families, large groups, and travelers seeking unique stays. With access to over 10 million properties in more than 150,000 destinations, Tripping.com offers a diverse range of options, including beach houses, condos, cabins, and apartments. The company emerged from TechCrunch Disrupt and has successfully secured multiple funding rounds, attracting investment from sources in Silicon Valley, New York, Europe, and Asia. As of December 2018, Tripping International operates as a subsidiary of HomeToGo GmbH.
Sauce Labs
Venture Round in 2016
Sauce Labs Inc. is a leading provider of cloud-based testing solutions for mobile and web applications, headquartered in San Francisco, California, with a data center in Frankfurt, Germany. Founded in 2008, the company offers a comprehensive testing platform that includes automated browser testing, mobile testing, and various testing services for different programming environments. Its flagship product, the Sauce Continuous Testing Cloud, has facilitated over 3 billion tests, enabling businesses to ensure their applications perform optimally across various browsers, operating systems, and devices. By delivering insights into the user experience, Sauce Labs helps organizations enhance software quality, protect their brand reputation, and speed up product delivery. Co-founded by the original creator of Selenium, Sauce Labs maintains strong ties to the open-source community, providing a unique blend of expertise and customer support in the automated testing space.
Carecloud
Series C in 2016
CareCloud Corporation is a healthcare information technology company based in Miami, Florida, founded in 2009. It specializes in cloud-based solutions, offering a comprehensive suite of services that includes practice management, electronic health records, revenue cycle management, and patient engagement tools. CareCloud caters to various medical specialties such as dermatology, family practice, ophthalmology, podiatry, rheumatology, and urology. By leveraging its innovative software-as-a-service platforms, the company aims to enhance profitability, streamline workflows, and improve patient care for medical groups across the United States. CareCloud's data-driven tools provide actionable insights, facilitating effective management of the financial and administrative aspects of healthcare delivery. The company currently manages over $4 billion in annualized accounts receivable on its integrated clinical and financial platform. As of early 2020, CareCloud operates as a subsidiary of MTBC, Inc.
TrendKite
Series D in 2016
TrendKite is an Austin, Texas-based company founded in 2012, specializing in public relations (PR) analytics software. The company's mission is to assist organizations in understanding public perception and responding effectively. TrendKite's platform provides comprehensive tools for measuring the impact of PR efforts on brand awareness, website traffic, and overall business objectives. It enables users to create automated or customizable dashboards that can swiftly analyze vast amounts of data, streamlining workflow and improving efficiency. The software is designed to help brands and agencies evaluate trends across various media types, generate insightful reports, and focus on the quality of media coverage rather than merely the quantity.
LogRhythm
Venture Round in 2016
LogRhythm, Inc. is a leading developer of a security intelligence and analytics platform that addresses the growing risks of cyber threats. Founded in 2003 and based in Boulder, Colorado, the company specializes in unifying various security functions, including next-generation security information and event management (SIEM), log management, network and endpoint forensics, and user and entity behavior analytics. This comprehensive platform empowers organizations to detect, respond to, and neutralize cyber threats effectively, enhancing their security operations across cloud, physical, and virtual environments. In addition to its core offerings, LogRhythm provides professional services, compliance solutions, and training to support clients in various sectors, including finance, healthcare, and government. The platform's capabilities also extend to operational intelligence, threat detection, and compliance automation, making it essential for modern enterprise security operations. With a global presence, LogRhythm serves a diverse clientele, including Fortune 500 companies, ensuring robust protection against increasingly sophisticated cyber risks.
Smule, Inc. is a San Francisco-based company that specializes in developing music applications aimed at connecting users through collaborative music creation. Founded in 2008, Smule's platform allows individuals to sing and produce music together, fostering a global community of music enthusiasts. Its popular products include AutoRap, Magic Piano, Guitar!, I Am T-Pain, and Ocarina, which enable users to create, discover, and enjoy music in innovative ways. By combining social interaction with music-making, Smule has established itself as a leader in the music app industry, facilitating connections between users and major artists worldwide.
Aptinyx Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing innovative therapies for brain and nervous system disorders. Founded in 2015 and based in Evanston, Illinois, the company focuses on novel, synthetic small molecules that modulate the NMDA receptor, enhancing communication pathways between nerve cells. Its primary products in development include NYX-2925, which is undergoing Phase II trials for painful diabetic peripheral neuropathy and fibromyalgia, and NYX-783, currently in Phase I trials for post-traumatic stress disorder. Additionally, Aptinyx is developing NYX-458, another NMDA receptor modulator, which is in Phase I clinical studies aimed at treating cognitive impairment associated with Parkinson’s disease. The company also collaborates with Allergan to develop compounds for major depressive disorder, underscoring its commitment to addressing significant unmet medical needs in the central nervous system arena.
Couchbase
Series F in 2016
Couchbase, Inc. is a provider of NoSQL databases tailored for enterprises, particularly for web and mobile applications. The company offers a comprehensive Couchbase platform that includes Couchbase Server, a high-performance distributed database, Couchbase Lite, an embedded database for mobile devices, and Couchbase Sync Gateway, which synchronizes data between mobile devices and the cloud. Additionally, Couchbase provides a cloud-native autonomous database management platform through its Kubernetes Operator and a fully-managed Database-as-a-Service (DBaaS) known as Couchbase Cloud. The platform is designed to handle massive data volumes in real time, making it suitable for industries such as social networking, online gaming, advertising, and e-commerce. Headquartered in Santa Clara, California, with an office in Manchester, United Kingdom, Couchbase was founded in 2008 and rebranded from Membase, Inc. in 2011. The company focuses on empowering developers to create innovative and personalized customer experiences through its agile and scalable database solutions.
Outpost Medicine
Series A in 2016
Outpost Medicine, founded in 2016 and based in the United States, focuses on developing innovative therapeutics for urologic and gynecologic diseases and disorders. The company is dedicated to addressing gastrointestinal and urologic conditions, with its lead clinical-stage product candidate, OP-233, aimed at treating stress urinary incontinence (SUI), a condition characterized by involuntary urine loss during physical activities. Additionally, Outpost is working on treatments for overactive bladder (OAB) and irritable bowel syndrome (IBS), reflecting its commitment to advancing healthcare solutions in these areas.
Millendo Therapeutics
Series B in 2016
Millendo Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for endocrine diseases resulting from hormone dysregulation. The company focuses on creating distinct and transformative therapies that address significant unmet medical needs in this area. By leveraging scientific advancements, Millendo aims to develop novel compounds that can effectively treat complex conditions, ultimately enhancing clinical care and improving the quality of life for patients, families, and caregivers.
HealthFinch
Series A in 2016
Healthfinch, Inc. is a healthcare IT company based in Madison, Wisconsin, founded in 2011. It specializes in developing technology that automates and simplifies routine clinical tasks, particularly focused on prescription renewal requests and visit planning. The company's flagship product, the Charlie Practice Automation Platform, integrates seamlessly with major electronic medical record (EMR) systems such as Allscripts, Epic, and athena. This platform leverages EMR data to streamline workflows, assisting healthcare providers in managing prescription refill requests, pre-visit planning, and identifying care gaps. As of July 31, 2020, Healthfinch operates as a subsidiary of Health Catalyst, Inc. Through its innovative solutions, the company aims to enhance the efficiency of clinics and healthcare systems in handling repetitive EMR tasks.
Skybox Security
Venture Round in 2016
Skybox Security, Inc. specializes in cybersecurity management solutions tailored for enterprises. The company offers a range of products designed to enhance security posture, including Skybox Horizon, which provides visibility into the attack surface and indicators of exposure. Skybox Vulnerability Control focuses on context-aware vulnerability management, while Skybox Threat Manager delivers threat intelligence analysis and response capabilities. Additional offerings include Skybox Firewall Assurance for firewall management and compliance, Skybox Change Manager for automated firewall change workflows, and Skybox Network Assurance for network visibility and control. These solutions are designed to help organizations map, prioritize, and remediate vulnerabilities across diverse corporate networks and cloud environments. Founded in 2002 and headquartered in San Jose, California, Skybox Security serves various industries, including financial services, government, energy, technology, telecommunications, and healthcare, with a global presence in multiple regions.
CBANC is an online professional network designed specifically for bank and credit union professionals. Established in 2009 and headquartered in Austin, Texas, the company provides a suite of tools that facilitate collaboration and information sharing among community financial institutions. Its offerings include resources for document management, discussions, vendor management, peer group analysis, and risk assessment. By leveraging the collective knowledge of its members, CBANC aims to empower employees within financial institutions to navigate compliance challenges, make informed vendor decisions, and enhance their professional development. Ultimately, the company is committed to supporting the independence and growth of community banking, fostering a healthier financial future for its members.
Earnest was built on the principle that getting a loan shouldn’t be difficult for financially responsible people. Earnest offers student loan refinancing and personal loan. It uses its unrivaled technology to consider more than just a credit score; it looks at thousands of data points such as education, saving patterns, investments, and career trajectory. Customers apply online and can manage their account payment preferences with the online dashboard and mobile app. Earnest was founded in 2013, by Louis Beryl and Ben Hutchinson, and had its official launch in early 2014. Earnest raised several rounds of funding from investors including Andreessen Horowitz, Maveron, Battery Ventures, Atlas Ventures, and several others. In 2017, Earnest was acquired by Navient Corp. Navient maintains Earnest as a separate brand while allowing Earnest to be backed by a larger company. Earnest has grown from distributing $8M loans in its first year of business to distributing nearly $2B in student loans and having a roughly $500M loan portfolio in 2017. Earnest has been included in Fast Company’s World’s 50 Most Innovative Companies list. The company lends across the United States in 45 states and the District of Columbia. In August 2017, it was announced that Earnest would open a second office in Salt Lake City, Utah.
MyHealthTeam
Series A in 2015
MyHealthTeams, Inc., established in 2011 and headquartered in San Francisco, develops and operates online social networking platforms for individuals living with or caring for those with chronic health conditions. The company's platforms, including MyAutismTeam, MyBCTeam, and others, connect users with similar conditions, enabling them to share experiences, seek advice, and access medically-approved content. MyHealthTeams also conducts research to inform clinical trial design and offers patient education programs.
Corvus Pharmaceuticals
Series B in 2015
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company based in Burlingame, California, dedicated to developing innovative immuno-oncology therapies. The company’s lead product candidate, Ciforadenant (CPI-444), is an oral small molecule antagonist of the A2A receptor and is currently undergoing Phase Ib/2 clinical trials. Additionally, Corvus is advancing CPI-006, an anti-CD73 monoclonal antibody, which is in Phase I/Ib trials aimed at inhibiting adenosine production and stimulating immune responses, as well as investigating its potential for treating COVID-19. Another candidate, CPI-818, is a small molecule that selectively inhibits interleukin-2-inducible T-cell kinase and is also in Phase I/Ib trials. Corvus Pharmaceuticals collaborates strategically with Angel Pharmaceuticals to enhance its pipeline of targeted investigational medicines. Founded in 2014, the company is focused on addressing significant unmet medical needs in cancer treatment and related diseases.
Cybera
Private Equity Round in 2015
Cybera, Inc. is a provider of Security-as-a-Service and networking solutions tailored for distributed enterprises in the United States and internationally. Established in 2000 and based in Franklin, Tennessee, the company offers a software-defined networking platform that combines security and networking functions, facilitating secure connections for multi-location businesses. Cybera's solutions cater to various sectors, including healthcare, retail, hospitality, and financial services, ensuring compliance with regulations such as PCI and HIPAA. By offering a secure application network overlay, Cybera simplifies network management and reduces complexity and costs for its clients. The company's services include endpoint protection and fully managed security solutions, designed to safeguard sensitive corporate data and protect consumers from identity theft. As of December 2020, Cybera operates as a subsidiary of Professional Datasolutions, Inc.
Orbus Therapeutics
Series A in 2015
Orbus Therapeutics, Inc. is a biopharmaceutical company based in Palo Alto, California, established in 2012. The company specializes in the development and commercialization of therapies aimed at treating brain cancers and other rare diseases. Its primary product, Eflornithine, is an orally bioavailable small molecule that acts as a cytostatic agent, specifically targeting recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. Orbus Therapeutics is dedicated to improving health outcomes for patients with life-threatening conditions by developing innovative medicinal products that inhibit tumor growth through the irreversible inhibition of the enzyme ornithine decarboxylase (ODC). The company is actively working on bringing Eflornithine to the North American market.
Apto, Inc. is a company that develops a cloud-based customer relationship and deal management software tailored for commercial real estate brokers. The platform provides tools for managing contacts, properties, listings, and deals, streamlining the entire deal lifecycle from prospecting to closing. Apto's software consolidates, organizes, and securely stores data in the cloud, ensuring that brokers can find, win, and execute deals efficiently while minimizing the risk of overlooking important details. Established in 2011 and headquartered in Denver, Colorado, Apto was previously known as McLabs, LLC.
RadiumOne
Series C in 2015
RadiumOne is a software company that specializes in programmatic marketing automation, enabling digital marketers to effectively utilize big data. Founded in 2009 and headquartered in San Francisco, California, the company offers a platform that automates media buying, connecting brands with potential customers by leveraging proprietary data on consumer behaviors, actions, and interests across various web and mobile touchpoints. This capability allows businesses to enhance customer engagement through relevant and personalized offers, messages, content, and advertisements, facilitating targeted marketing across multiple devices and locations.
Chrome River Technologies
Series D in 2015
Chrome River Technologies, Inc. specializes in automated expense and invoice management solutions designed for a variety of industries, including legal, healthcare, and technology. Founded in 2007 and headquartered in Los Angeles, with additional offices in Canada, the United Kingdom, Germany, France, India, and Australia, the company offers a suite of cloud-based products. These include Chrome River EXPENSE, which ensures real-time compliance with spending policies, and Chrome River INVOICE, which streamlines the invoice management process. The company also provides tools for fraud management, corporate card reconciliation, and expense reporting, complemented by robust analytics capabilities. With a focus on delivering an intuitive user experience across devices, Chrome River Technologies aims to enhance operational efficiency and support organizations in managing their financial workflows effectively. As of 2019, it operates as a subsidiary of Certify Inc.
Smule, Inc. is a San Francisco-based company that specializes in developing music applications aimed at connecting users through collaborative music creation. Founded in 2008, Smule's platform allows individuals to sing and produce music together, fostering a global community of music enthusiasts. Its popular products include AutoRap, Magic Piano, Guitar!, I Am T-Pain, and Ocarina, which enable users to create, discover, and enjoy music in innovative ways. By combining social interaction with music-making, Smule has established itself as a leader in the music app industry, facilitating connections between users and major artists worldwide.